Uruganda rukora imiti rwa Changzhou Ltd,ishami rya Pharmaceutical Holdings ya Shanghai, yakiriye icyemezo cyo kwiyandikisha ku biyobyabwenge (Icyemezo No 2021S01077, 2021S01078, 2021S01079) cyatanzwe n’ikigo cya Leta gishinzwe ibiyobyabwenge kuriLenalidomide Capsules(Ibisobanuro 5mg, 10mg, 25mg), byemejwe kubyara umusaruro.
Amakuru y'ibanze
Izina ry'ibiyobyabwenge:Lenalidomide capsules
Ifishi ikoreshwa:Capsule
Ibisobanuro:5mg, 10mg, 25mg
Ibyiciro byo kwiyandikisha:Imiti yimiti 4
Umubare w'icyiciro:Icyemezo cya Leta cy’ibiyobyabwenge H20213802, Icyemezo cya Leta cy’ibiyobyabwenge H20213803, Icyemezo cya Leta cy’ibiyobyabwenge H20213804
Umwanzuro wo kwemeza: Kuzuza ibisabwa byo kwandikisha ibiyobyabwenge, byemejwe kwiyandikisha, utanga icyemezo cyo kwandikisha ibiyobyabwenge.
Ibisobanuro bijyanye
Lenalidomideni igisekuru gishya cy'imiti ikingira indwara yo mu kanwa ifite umurimo wo guhagarika ikwirakwizwa ry'uturemangingo tw'ibibyimba, gutera kanseri y'ibibyimba apoptose na immunomodulation, ikoreshwa cyane mu kuvura indwara ya myeloma na myelodysplastic syndrome (MDS) n'ibindi bihe. Ikoreshwa ifatanije na dexamethasone mu kuvura abarwayi bakuze bafite myeloma myinshi itavuwe mbere itari abakandida ba transplant. Iki gicuruzwa gikoreshwa hamwe na dexamethasone mu kuvura abarwayi bakuze bafite myeloma nyinshi bakiriye byibuze imiti imwe yabanje. Iki gicuruzwa gikoreshwa hamwe na rituximab mu kuvura abarwayi bakuze bafite lymphoma ya follicular (icyiciro cya 1-3a) bakiriye mbere yo kuvurwa.
Capsules ya Lenalidomide yatunganijwe bwa mbere na Celgene Biopharmaceuticals ikanashyirwa ku isoko muri Amerika mu 2005. Ukuboza 2019, Uruganda rwa Farumasi rwa Changzhou rwatanze icyifuzo cyo kwiyandikisha no kwamamaza mu kigo cya Leta gishinzwe ibiyobyabwenge ku biyobyabwenge, biremerwa.
Amakuru yaturutse muri Minene.com yerekana ko igurishwa ry’igihugu rya Nalidomide capsules muri 2020 rizaba hafi miliyari 1.025.
Dukurikije politiki y’igihugu ibishinzwe, ubwoko bw’ibiyobyabwenge rusange byemejwe hakurikijwe ibyiciro bishya byo kwiyandikisha bizahabwa inkunga nyinshi nko kwishyura ubwishingizi bw’ubuvuzi no gutanga amasoko y’ubuvuzi. Kubwibyo, umusaruro wemewe waUruganda rwa farumasi rwa Changzhou's lenalidomidecapsule ifasha kurushaho kwagura isoko ryayo mubijyanye no kuvura indwara ya hematologiya-ibibyimba no kongera isoko ryayo ku isoko, ndetse no gukusanya uburambe bw'agaciro ku bicuruzwa byakurikiyeho kugira ngo bikore iterambere rusange ry'ibiyobyabwenge no gutanga dosiye.